CSL Behring Denmark

Recent executive movements at CSL

David Lamont, Chief Financial Officer, will leave the company on Oct. 30, 2020  (news posted on June 17 2020).

Create an alert
to follow the executive moves at CSL Behring Denmark.

Most searched biographies at CSL Behring Denmark

• Gitte Stausholm, General Manager
• Mette Toft Jacobsen, Area Sales Manager
• Charlotte Louise Krebs, Key Account and Market Access Manager

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Roivant Sciences has announced the acquisition of Silicon Therapeutics (posted on Feb 26, 2021).
Merck has announced the acquisition of Pandion Therapeutics (posted on Feb 26, 2021).
Charles River Laboratories International has announced the acquisition of Cognate BioServices (posted on Feb 18, 2021).

Other contacts in the Biotechnology industry

• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Chandra Leo - Director at Gynesonics
• Stephen Hoge - Director at Axcella Health

Learn more about the Biotechnology industry >

Latest news about CSL Behring Denmark

CSL Behring Denmark on Wikipedia, Google News & Yahoo Finance

CSL Behring Denmark on LinkedIn, Twitter & YouTube

CSL Behring Denmark has 1,573 competitors including Biogen (United States (USA)), Neptune Wellness Solutions (Canada) and Eurofins (France). CSL Behring Denmark is owned by CSL Behring.

Contact by email its executives including Gitte Stausholm

Call CSL Behring Denmark at +45 ....

View the org chart

Register to receive your alert

Report an error